ArticlePharmacoepidemiology and drug safety2022

Trends in the use of disease-modifying therapies among reproductive-aged women with multiple sclerosis in the United States from 2010 to 2019.

Emilie D Duchesneau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.